ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,624Medicare Part D Prescriptions Filled, Including Refills

Rank: 55 out of 546

$473K Total Retail Price of All Prescriptions

Rank: 64 out of 546

351 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Maine
Lower avg

Schedule Two
Controlled Substances

16% of this provider’s 351 patients filled at least one prescription for a schedule two drug, compared to an average of 9%.

Schedule Three
Controlled Substances

17% of this provider’s 351 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 4,793 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Maine
SIMVASTATIN 396 261 1 2
HYDROCODONE-ACETAMINOPHEN 376 154 S3 2 8
OXYCODONE HCL 203 47 S2 3 15
LEVOTHYROXINE SODIUM 190 143 4 3
OMEPRAZOLE 181 108 5 4
HYDROCHLOROTHIAZIDE 180 156 6 7
METFORMIN HCL 176 94 7 10
LISINOPRIL 157 114 8 1
METOPROLOL TARTRATE 156 138 9 6
ZOLPIDEM TARTRATE 142 85 10 26
AMLODIPINE BESYLATE 137 116 11 9
PANTOPRAZOLE SODIUM 129 108 12 18
FUROSEMIDE 106 96 13 5
OXYCODONE-ACETAMINOPHEN 104 64 S2 14 54
RANITIDINE HCL 104 66 14 23
ATORVASTATIN CALCIUM 103 71 16 11
RISPERIDONE 102 31 17 47
ATENOLOL 101 81 18 12
TRAMADOL HCL 97 29 19 19
SERTRALINE HCL 90 49 20 14
OXYCODONE HCL-ACETAMINOPHEN 89 54 S2 21 101
FLUOXETINE HCL 84 28 22 39
PROPRANOLOL HCL 77 37 23 99
METOPROLOL SUCCINATE 75 63 24 17
WARFARIN SODIUM 75 47 24 13
FAMOTIDINE 72 64 26 53
ACETAMINOPHEN-CODEINE 71 62 S3 27 113
GLYBURIDE 70 54 R 28 45
PREDNISONE 62 54 29 29
TAMSULOSIN HCL 62 62 29 35
VENTOLIN HFA 59 34 31 63
MELOXICAM 59 33 31 58
ADVAIR DISKUS 57 47 33 20
OXYCONTIN 55 33 S2 34 75
AMITRIPTYLINE HCL 54 30 R 35 48
NAPROXEN 52 34 36 107
PAROXETINE HCL 51 24 37 43
ACTOS 50 41 38 129
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 21, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.